Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Valneva SE

Start price
Target price
Perf. (%)
€12.34
13.09.21
€9.00
13.09.22
100.65%
16.12.21

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
13.09.21 90%
buy
Theranexus

Start price
Target price
Perf. (%)
€9.02
11.09.21
€10.00
11.09.22
-64.80%
04.02.22

Could be worthwhile Investment >10% per year
melinda 
11.09.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.72
11.09.21
€30.00
11.09.22
-38.66%
21.08.22

Geldmacher 
11.09.21 90%
sell
Inventiva SA

Start price
Target price
Perf. (%)
€11.54
10.09.21
€8.00
10.09.22
-63.65%
11.09.22

Could be worthwhile Investment >10% per year
melinda 
10.09.21 50%
buy
Inventiva SA

Start price
Target price
Perf. (%)
€2.79
10.09.21
€12.00
-
10.09.21

Could be worthwhile Investment >10% per year
melinda 
10.09.21 50%
sell
Inventiva SA

Start price
Target price
Perf. (%)
€2.79
10.09.21
€8.00
-
10.09.21

Could be worthwhile Investment >10% per year
melinda 
10.09.21 50%
sell
Poxel S.A.

Start price
Target price
Perf. (%)
€6.46
06.09.21
€5.00
06.09.22
-9.30%
07.10.21

Could be worthwhile Investment >10% per year
melinda 
06.09.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€20.78
06.09.21
-
06.09.22
-39.56%
13.09.21

Risky Investment
thomasw 
06.09.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€20.60
05.09.21
-
05.09.22
-43.93%
19.09.21

bundfuture 
05.09.21 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.80
05.09.21
-
05.09.22
-47.79%
07.03.22

Probably not worthwhile Investment
Lokrim 
05.09.21 10%
sell
Innate Pharma

Start price
Target price
Perf. (%)
€4.80
04.09.21
€2.00
04.09.22
37.71%
18.09.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
nvestor 
04.09.21 50%
sell
Innate Pharma

Start price
Target price
Perf. (%)
€6.20
03.09.21
-
03.09.22
-25.29%
06.09.21

Risky Investment
thomasw 
03.09.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€20.18
03.09.21
€30.00
03.09.22
-59.38%
03.09.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Higher risks for its business
tbackenh 
03.09.21 60%
buy
Advicenne

Start price
Target price
Perf. (%)
€7.78
31.08.21
€10.00
30.05.22
-6.94%
17.10.21

Could be worthwhile Investment >10% per year
melinda 
31.08.21 50%
sell
Advicenne

Start price
Target price
Perf. (%)
€1.96
31.08.21
€10.00
30.05.22
-
31.08.21

Could be worthwhile Investment >10% per year
melinda 
31.08.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€13.84
25.08.21
-
25.08.22
-32.23%
26.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
shadow 
25.08.21 0%
buy
Theradiag S.A.

Start price
Target price
Perf. (%)
€1.90
16.08.21
€2.40
16.08.22
-14.53%
17.08.22

krebskrebs 
16.08.21 50%
sell
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€5.10
30.07.21
-
30.07.22
2.55%
08.08.21

Risky Investment
Vassago1 
30.07.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.24
20.07.21
€20.00
20.07.22
116.90%
25.11.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
20.07.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.85
08.07.21
-
08.07.22
-11.18%
08.07.22

Saftman 
08.07.21 50%
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€155.60
08.07.21
€195.00
08.07.22
8.64%
18.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
08.07.21 80%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€86.85
08.07.21
€115.00
08.07.22
13.32%
08.07.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
08.07.21 80%
sell
Abivax S.A.

Start price
Target price
Perf. (%)
€30.50
28.06.21
€25.00
28.06.22
-16.39%
01.12.21

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Snowman 
28.06.21 50%
buy
Neovacs

Start price
Target price
Perf. (%)
€528,000
22.06.21
€240,000,000
22.06.22
-99.70%
23.06.22

JuKra95 
22.06.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€10.89
17.06.21
€8.00
17.06.22
3.21%
20.07.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
17.06.21 50%